NaviCam Patency Capsule to Verify Gastrointestinal Patency
Part of paid clinical trials in Downers Grove, Illinois.
- Sponsor
- AnX Robotica Corp.
- Study ID
- NCT07649720
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Abdominal Pain
- Crohn Disease
- Intestinal Stricture
- NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- NaviCam Patency Capsule — DEVICEThe NaviCam Patency Capsule is an accessory to the NaviCam capsule and is intended to verify adequate patency of the gastrointestinal tract prior to administration of the NaviCam capsule in patients with known or suspected strictures.
Study Details
Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.
Key Dates
- Start date
- Jun 15, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 15, 2026
- Completion
- Mar 15, 2027
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Single arm patency capsule evaluationParticipants will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm whether the capsule is still in the body.
Primary Outcome Measure
Safety of patency capsule [ Time Frame: 30 hours ]
Central Contacts
- Tim Thomas, RAC770-480-2911
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Digestive Health Services | Downers Grove | Illinois | 60515 |
Find similar trials in Downers Grove, IL
By condition
By research site
Related Studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic RemissionRecruiting · University of California, San Diego · Irvine, California
- Utility of Random Biopsies in Patients With Inflammatory Bowel DiseaseEnrolling By Invitation · Abramson Cancer Center at Penn Medicine · Birmingham, Alabama
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseasePHASE2 · Recruiting · Eli Lilly and Company · Scottsdale, Arizona